Special Economic Zone

Dishman abandons SEZ plans pharma India economics debts

Dishman abandons pharma SEZ plan

By Gareth Macdonald

Dishman Pharmaceuticals has abandoned plans to set up a special economic zone (SEZ) citing law changes that make the project less attractive and unfavourable economics as the reasons for the decision.  

Manufacturing expansions round-up

Manufacturing expansions round-up

By Natalie Morrison

in-PharmaTechnologist brings you a round-up of the latest new facilities and expansions for drugsmakers, including added cytotoxic capabilities for BTL, Jubilant’s launch of a special economic zone in India and plans for a $20m API plant for Omkar.


Follow us


Featured Suppliers